Traumatic Brain Injuries Treatment Market Research Report - Forecast till 2030

Traumatic Brain Injuries (TBI) Treatment Market Research Report: by treatment (immediate emergency care, medications (diuretics, analgesic and others), surgery), end-users (hospitals, neurologist, independent pharmacies and others) -Forecast till 2030

ID: MRFR/Pharma/5374-HCR | August, 2022 | Region : Global

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Traumatic Brain Injury Treatment Market , by Treatment

6.1 Introduction

6.2 Immediate emergency care

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Medications

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.1 Diuretics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.2 Anti-seizure drugs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.3 Coma-inducing drugs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.4 Anti-Anxiety Agent

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.5 Anti-Depressants

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.6 Anti-Psychotics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.7 Analgesic

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.8 Anti-Convulsants,

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.9 Anti-Coagulants

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Surgery

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4.1 Removing clotted blood (hematomas)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4.2 Repairing skull fractures

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4.3 Bleeding in the brain

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4.5 Opening a window in the skull

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4.6 Rehabilitation

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Traumatic Brain Injury Treatment Market , by End-User

7.1 Introduction

7.2 Hospitals

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Neurologist

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 Independent Pharmacies

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5 Rehabilitative Center Treatment

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6 Other

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8. Global Traumatic Brain Injury Treatment Market , by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9 Company Landscape


9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 Zimmer Biomet

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Neuren Pharmaceuticals Ltd

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Oxygen Biotherapeutics Inc

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 TEVA Pharmaceutical Industries Ltd

10.4.1 Company Overview

10.4.2 Product Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Ischemic

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Grace Laboratories LLC

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Cognosci

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financial Overview

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Medicortex

10.8.1 Overview

10.8.2 Product Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.7 Amarantus BioScience Holdings

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financials

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Aldagen

10.8.1 Overview

10.8.2 Product Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.11 NeuroScience Pharmaceuticals

10.91 Overview

10.92 Product Overview

10.93 Financials

10.94 Key Developments

10.95 SWOT Analysis

10.10 Targacept

10.10.1 Overview

10.10.2 Product Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.13 BioDirection, Inc

10.13.1 Overview

10.13.2 Product Overview

10.13.3 Financials

10.13.4 Key Developments

10.13.5 SWOT Analysis

10.14 QuesGen Systems, Inc

10.14.1 Overview

10.14.2 Product Overview

10.14.3 Financials

10.14.4 Key Developments

10.14.5 SWOT Analysis

10.15 BrainScope Company, Inc

10.15.1 Overview

10.15.2 Product Overview

10.15.3 Financials

10.15.4 Key Developments

10.15.5 SWOT Analysis

10.16 Neural Analytics, Inc

10.16.1 Overview

10.16.2 Product Overview

10.16.3 Financials

10.16.4 Key Developments

10.16.5 SWOT Analysis

10.17 Oculogica

10.17.1 Overview

10.17.2 Product Overview

10.17.3 Financials

10.17.4 Key Developments

10.17.5 SWOT Analysis

10.18 BrainScope Company, Inc

10.18.1 Overview

10.18.2 Product Overview

10.18.3 Financials

10.18.4 Key Developments

10.18.5 SWOT Analysis

10.19 Silver Creek Pharmaceuticals Inc

10.19.1 Overview

10.19.2 Product Overview

10.19.3 Financials

10.19.4 Key Developments

10.19.5 SWOT Analysis

10.20 Stemedica Cell Technologies Inc

10.20.1 Overview

10.20.2 Product Overview

10.20.3 Financials

10.20.4 Key Developments

10.20.5 SWOT Analysis

10.21 Banayan Biomarkers Inc

10.21.1 Overview

10.21.2 Product Overview

10.21.3 Financials

10.21.4 Key Developments

10.21.5 SWOT Analysis

10.22 Vasopharm GmbH

10.22.1 Overview

10.22.2 Product Overview

10.22.3 Financials

10.22.4 Key Developments

10.22.5 SWOT Analysis

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s View point

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Predictions for the Traumatic Brain Injury Treatment Market

Chapter 12. Appendix

 

LIST OF TABLES

Table 1 Global Traumatic Brain Injury Treatment Market Synopsis, 2020–2027

Table 2 Global Traumatic Brain Injury Treatment Market Estimates and Forecast, 2020–2027

(USD Million)

Table 3 Global Traumatic Brain Injury Treatment Market , by Region, 2020–2027 (USD Million)

Table 4 Global Traumatic Brain Injury Treatment Market , by Treatment , 2020–2027 (USD Million)

Table 5 Global Traumatic Brain Injury Treatment Market , by End-User, 2020–2027 (USD Million)

Table 6 North America: Traumatic Brain Injury Treatment Market , by Treatment , 2020–2027 (USD Million)

Table 7 North America: Traumatic Brain Injury Treatment Market , by End-User, 2020–2027

(USD Million)

Table 8 US: Traumatic Brain Injury Treatment Market , by Treatment , 2020–2027 (USD Million)

Table 9 US: Traumatic Brain Injury Treatment Market , by End-User, 2020–2027 (USD Million)

Table 10 Canada: Traumatic Brain Injury Treatment Market ,by Treatment , 2020–2027

(USD Million)

Table 11 Canada: Traumatic Brain Injury Treatment Market , by End-User, 2020–2027

(USD Million)

Table 12 South America: Traumatic Brain Injury Treatment Market , by Treatment , 2020–2027 (USD Million)

Table 13 South America: Traumatic Brain Injury Treatment Market , by End-User, 2020–2027 (USD Million)

Table 14 Europe: Traumatic Brain Injury Treatment Market , by Treatment , 2020–2027

(USD Million)

Table 15 Europe: Traumatic Brain Injury Treatment Market , by End-User, 2020–2027

(USD Million)

Table 16 Western Europe: Traumatic Brain Injury Treatment Market , by Treatment , 2020–2027 (USD Million)

Table 17 Western Europe: Traumatic Brain Injury Treatment Market , by End-User, 2020–2027 (USD Million)

Table 20 Eastern Europe: Traumatic Brain Injury Treatment Market , by Treatment , 2020–2027 (USD Million)

Table 19 Eastern Europe: Traumatic Brain Injury Treatment Market , by End-User, 2020–2027 (USD Million)

Table 20 Asia-Pacific: Traumatic Brain Injury Treatment Market , by Treatment , 2020–2027

(USD Million)

Table 21 Asia-Pacific: Traumatic Brain Injury Treatment Market , by End-User, 2020–2027

(USD Million)

Table 22 Middle East & Africa: Traumatic Brain Injury Treatment Market , by Treatment, 2020-2027 (USD Million)

Table 23 Middle East & Africa: Traumatic Brain Injury Treatment Market , by End-User, 2020–2027 (USD Million)


 


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Traumatic Brain Injury Treatment Market

Figure 3 Segmentation Market Dynamics for Global Traumatic Brain Injury Treatment Market

Figure 4 Global Traumatic Brain Injury Treatment Market Share, by Treatment , 2020

Figure 5 Global Traumatic Brain Injury Treatment Market Share, by End-User, 2020

Figure 6 Global Traumatic Brain Injury Treatment Market Share, by Region, 2020

Figure 7 North America: Traumatic Brain Injury Treatment Market Share, by Country, 2020

Figure 8 Europe: Traumatic Brain Injury Treatment Market Share, by Country, 2020

Figure 9 Asia-Pacific: Traumatic Brain Injury Treatment Market Share, by Country, 2020

Figure 10 Middle East & Africa: Traumatic Brain Injury Treatment Market Share, by Country, 2020

Figure 11 Global Traumatic Brain Injury Treatment Market : Company Share Analysis, 2020 (%)

Figure 12 Zimmer Biomet: Key Financials

Figure 13 Zimmer Biomet: Segmental Revenue

Figure 14 Zimmer Biomet: Geographical Revenue

Figure 15 Neuren Pharmaceuticals Ltd: Key Financials

Figure 16 Neuren Pharmaceuticals Ltd: Segmental Revenue

Figure 17 Neuren Pharmaceuticals Ltd: Geographical Revenue

Figure 20 Oxygen Biotherapeutics Inc: Key Financials

Figure 19 Oxygen Biotherapeutics Inc: Segmental Revenue

Figure 20 Oxygen Biotherapeutics Inc: Geographical Revenue

Figure 21 TEVA Pharmaceutical Industries Ltd : Key Financials

Figure 22 TEVA Pharmaceutical Industries Ltd: Segmental Revenue

Figure 23 TEVA Pharmaceutical Industries Ltd : Geographical Revenue

Figure 24 Ischemic: Key Financials

Figure 25 Ischemic: Segmental Revenue

Figure 26 Ischemic. Geographical Revenue

Figure 27 Grace Laboratories LLC: Key Financials

Figure 28 Grace Laboratories LLC: Segmental Revenue

Figure 29 Grace Laboratories LLC: Geographical Revenue

Figure 30 Cognosci: Key Financials

Figure 31 Cognosci: Segmental Revenue

Figure 32 Cognosci: Geographical Revenue

Figure 33 Medicortex: Key Financials

Figure 34 Medicortex: Segmental Revenue

Figure 35 Medicortex: Geographical Revenue

Figure 36 Amarantus BioScience Holdings: Key Financials

Figure 37 Amarantus BioScience Holdings: Segmental Revenue

Figure 38 Amarantus BioScience Holdings: Geographical Revenue

Figure 39 Aldagen: Key Financials

Figure 40 Aldagen: Segmental Revenue

Figure 41 Aldagen: Geographical Revenue

Figure 42 NeuroScience Pharmaceuticals : Key Financials

Figure 43 NeuroScience Pharmaceuticals : Segmental Revenue

Figure 44 NeuroScience Pharmaceuticals : Geographical Revenue

Figure 45 Targacept: Key Financials

Figure 46 Targacept: Segmental Revenue

Figure 47 Targacept: Geographical Revenue

Figure 48 BioDirection, Inc: Key Financials

Figure 49 BioDirection, Inc: Segmental Revenue

Figure 50 BioDirection, Inc: Geographical Revenue

Figure 51 QuesGen Systems, Inc: Key Financials

Figure 52 QuesGen Systems, Inc: Segmental Revenue

Figure 53 QuesGen Systems, Inc: Geographical Revenue

Figure 54 BrainScope Company, Inc, Inc: Key Financials

Figure 55 BrainScope Company, Inc, Inc: Segmental Revenue

Figure 56 BrainScope Company, Inc, Inc: Geographical Revenue

Figure 57 Neural Analytics, Inc, Inc: Key Financials

Figure 58 Neural Analytics, Inc, Inc: Segmental Revenue

Figure 59 Neural Analytics, Inc, Inc: Geographical Revenue

Figure 60 Oculogica, Inc: Key Financials

Figure 61 Oculogica, Inc: Segmental Revenue

Figure 62 Oculogica, Inc: Geographical Revenue

Figure 63 BrainScope Company, Inc: Key Financials

Figure 64 BrainScope Company, Inc: Segmental Revenue

Figure 65 BrainScope Company, Inc: Geographical Revenue

Figure 66 Silver Creek Pharmaceuticals Inc: Key Financials

Figure 67 Silver Creek Pharmaceuticals Inc: Segmental Revenue

Figure 68 Silver Creek Pharmaceuticals Inc: Geographical Revenue

Figure 69 Stemedica Cell Technologies Inc: Key Financials

Figure 70 Stemedica Cell Technologies Inc: Segmental Revenue

Figure 71 Stemedica Cell Technologies Inc: Geographical Revenue

Figure 72 Banayan Biomarkers Inc: Key Financials

Figure 73 Banayan Biomarkers Inc: Segmental Revenue

Figure 74 Banayan Biomarkers Inc: Geographical Revenue

Figure 75 Vasopharm GmbH: Key Financials

Figure 76 Vasopharm GmbH: Segmental Revenue

Figure 77 Vasopharm GmbH: Geographical Revenue

Traumatic Brain Injuries (TBI) Treatment Market

Traumatic brain injuries treatment market is expected to grow to reach USD 267.4 billion by 2027, at a CAGR of around 5.65% during the forecast period

Segmentation

By Treatment Immediate Emergency Care Medications Surgery
End-users Hospitals Neurologist Independent Pharmacies And Others

Key Players

  • Zimmer Biomet
  • Neuren Pharmaceuticals Ltd.
  • Oxygen Biotherapeutics Inc
  • Teva Pharmaceutical Industries Ltd
  • Ischemic
  • Grace Laboratories LLC
  • Cognosci
  • Medicortex
  • Amarantus BioScience Holdings
  • Aldagen

Drivers

  • rising populations
  • technologically advanced products and equipment
  • increased the number of patients
Speak to Analyst Request a Free Sample